Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-19

Clinical Trial Update: MIRODERM™ for Complex Wounds in an Inpatient Setting (MIRODERM CLOSure) [NA]

View source ↗

Summary

Miromatrix Medical’s MIRODERM CLOSure trial for complex wounds in an inpatient setting has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIRODERM CLOSure

Snippet

Sponsor: Miromatrix Medical Inc. | Conditions: Complex Wound | NA | Status: WITHDRAWN